The future promise and the current reality of genetic prognostication in patients with uveal melanoma

Archives of Ophthalmology

Volumn 126, Issue 3, 2008, Pages 413-415

  Tsai, Tony ^a   O'Brien, Joan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DACARBAZINE; FOTEMUSTINE; INTERFERON; INTERLEUKIN 2; TAMOXIFEN; VINBLASTINE;

ASPIRATION BIOPSY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; ENUCLEATION; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; IMMUNOSCINTIGRAPHY; INTRAOCULAR TUMOR; LIVER METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; TREATMENT RESPONSE; UVEA MELANOMA;

BIOPSY, FINE-NEEDLE; CYTOGENETIC ANALYSIS; FORECASTING; HUMANS; MELANOMA; MICROSATELLITE REPEATS; PROGNOSIS; UVEAL NEOPLASMS;

EID: 40849118108     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.126.3.413     Document Type: Review

References (27)

1. Singh AD, Topham A. Survival rates with uveal melanoma in the United States: 1973-1997. Ophthalmology. 2003;110(5):962-965.
2. Kujala E, Makitie T, Kivela T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44(11):4651- 4659.
3. Eskelin S, Pyrhonen S, Summanen P, Hahka-Kemppinen M, Kivela T. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology. 2000;107(8):1443-1449.
4. Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, V: twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol. 2006;124(12): 1684-1693.
5. Singh AD, Shields CL, Shields JA. Prognostic factors in uveal melanoma. Melanoma Res. 2001; 11(3):255-263.
6. Ehlers JP, Harbour JW. Molecular pathobiology of uveal melanoma. Int Ophthalmol Clin. 2006; 46(1):167-180.
7. Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jockel KH, Becher R. Prognostic implications of monosomy 3 in uveal melanoma. Lancet. 1996; 347(9010):1222-1225.
8. Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 2004;64(20):7205-7209.
9. Worley LA, Onken MD, Person E, et al. Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clin Cancer Res. 2007;13(5):1466-1471.
10. Midena E, Bonaldi L, Parrozzani R, Tebaldi E, Boccassini B, Vujosevic S. In vivo detection of monosomy 3 in eyes with medium-sized uveal melanoma using transscleral fine needle aspiration biopsy. Eur J Ophthalmol. 2006;16(3):422-425.
11. Young TA, Rao NP, Glasgow BJ, Moral JN, Straatsma BR. Fluorescent in situ hybridization for monosomy 3 via 30-gauge fine-needle aspiration biopsy of choroidal melanoma in vivo. Ophthalmology. 2007;114(1):142-146.
12. Shields CL, Ganguly A, Materin MA, et al. Chromosome 3 analysis of uveal melanoma using fineneedle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, Lectureship. Arch Ophthalmol. 2007; 125(8):1017-1024.
13. Shields JA, Shields CL, Ehya H, Eagle RC Jr, De Potter P. Fine-needle aspiration biopsy of suspected intraocular tumors: The 1992 Urwick Lecture. Ophthalmology. 1993;100(11):1677-1684.
14. Callejo SA, Antecka E, Blanco PL, Edelstein C, Burnier MN. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma: a prospective longitudinal study. Eye. 2007;21(6): 752-759.
15. Schaling DF, Oosterhuis JA, Jager MJ, Kakebeeke-Kemme H, Pauwels EK. Possibilities and limitations of radioimmunoscintigraphy and conventional diagnostic modalities in choroidal melanoma. Br J Ophthalmol. 1994;78(4):244-248.
16. Bedikian AY. Metastatic uveal melanoma therapy: current options. Int Ophthalmol Clin. 2006;46 (1):151-166.
17. Bedikian AY, Kantarjian H, Young SE, Bodey GP. Prognosis in metastatic choroidal melanoma. South Med J. 1981;74(5):574-577.
18. Bedikian AY, Legha SS, Mavligit G, et al. Treatment of uveal melanoma metastatic to the liver: a review of the M.D. Anderson Cancer Center experience and prognostic factors. Cancer. 1995; 76(9):1665-1670.
19. Albert DM, Ryan LM, Borden EC. Metastatic ocular and cutaneous melanoma: a comparison of patient characteristics and prognosis. Arch Ophthalmol. 1996;114(1):107-108.
20. Flaherty LE, Unger JM, Liu PY, Mertens WC, Sondak VK. Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trials. Am J Clin Oncol. 1998;21(6):568-572.
21. Diener-West M, Reynolds SM, Agugliaro DJ, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol. 2005;123(12):1639-1643.
22. Aoyama T, Mastrangelo MJ, Berd D, et al. Protracted survival after resection of metastatic uveal melanoma. Cancer. 2000;89(7):1561-1568.
23. Gündüz K, Shields JA, Shields CL, Sato T, Mastrangelo MJ. Surgical removal of solitary hepatic metastasis from choroidal melanoma. Am J Ophthalmol. 1998;125(3):407-409.
24. Salmon RJ, Levy C, Plancher C, et al. Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Eur J Surg Oncol. 1998;24(2):127-130.
25. Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol. 2003; 10(9):1059-1069.
26. Peters S, Voelter V, Zografos L, et al. Intraarterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients. Ann Oncol. 2006;17(4): 578-583.
27. Yang H, Grossniklaus HE. Combined immunologic and anti-angiogenic therapy reduces hepatic micrometastases in a murine ocular melanoma model. Curr Eye Res. 2006;31(6):557-562.